Screening for cognitive impairment in human immunodeficiency virus

Clinical Infectious Diseases

Volumn 53, Issue 8, 2011, Pages 836-842

  Valcour, Victor ^a,b   Paul, Robert ^c   Chiao, Stephanie ^a   Wendelken, Lauren A ^a   Miller, Bruce ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MISSOURI ST LOUIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; BRAIN ATROPHY; CLINICAL ASSESSMENT TOOL; COGNITIVE DEFECT; COMPUTER ANALYSIS; DEMENTIA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV DEMENTIA SCALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUSASSOCIATED NEUROCOGNITIVE DISORDER; INTERNATIONAL HIV DEMENTIA SCALE; MINI MENTAL STATE EXAMINATION; MODIFIED HIV DEMENTIA SCALE; MONTREAL COGNITIVE ASSESSMENT; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SCREENING TEST;

AGING; COGNITION DISORDERS; HIV INFECTIONS; HUMANS; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; SENSITIVITY AND SPECIFICITY;

EID: 80052891622     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir524     Document Type: Review

References (41)

1. Heaton RK, Clifford DB, Franklin DR Jr, et al. CHARTER Group. HIVassociated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 2010; 75:2087-96.
2. Heaton RK, Marcotte TD, Mindt MR, et al. HNRC Group. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 2004; 10:317-31. (Pubitemid 38779804)
3. Vivithanaporn P, Heo G, Gamble J, et al. Neurologic disease burden in treated HIV/AIDS predicts survival: A population-based study. Neurology 2010; 75:1150-8.
4. Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007; 69: 1789-99. (Pubitemid 350059308)
5. Heaton RK, Franklin DR, Ellis RJ, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 2011; 17:3-16.
6. Thames AD, Kim MS, Becker BW, et al. Medication and finance management among HIV-infected adults: The impact of age and cognition. J Clin Exp Neuropsychol 2011; 33:200-9.
7. Valcour V, McMurtray A. Interactions betweeen advanced age and HIV cognitive impairment. In: Paul R, Sacktor N, Valcour V, Tashima K eds. HIV and the brain: New challenges in the modern era. Towota, NJ: Humana Press, 2008.
8. Ellis R, Langford D, Masliah E. HIV and antiretroviral therapy in the brain: Neuronal injury and repair. Nat Rev Neurosci 2007; 8:33-44. (Pubitemid 46011997)
9. Esiri MM, Biddolph SC, Morris CS. Prevalence of Alzheimer plaques in AIDS. J Neurol Neurosurg Psychiatry 1998; 65:29-33. (Pubitemid 28302353)
10. Ances BM, Christensen JJ, Teshome M, et al. Cognitively unimpaired HIV-positive subjects do not have increased 11C-PiB: A case-control study. Neurology 2010; 75:111-5.
11. Gray F, Adle-Biassette H, Chretien F, Lorin de la Grandmaison G, Force G, Keohane C. Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. Clin Neuropathol 2001; 20:146-55.
12. Valcour V, Watters MR, Williams AE, Sacktor N, McMurtray A, Shikuma C. Aging exacerbates extrapyramidal motor signs in the era of highly active antiretroviral therapy. J Neurovirol 2008; 5:362-7. (Pubitemid 352762875)
13. Woods SP, Scott JC, Dawson MS, et al. Construct validity of Hopkins Verbal Learning Test-Revised component process measures in an HIV-1 sample. Arch Clin Neuropsychol 2005; 20:1061-71. (Pubitemid 41642942)
14. Borson S, Scanlan JM, Watanabe J, Tu SP, Lessig M. Improving identification of cognitive impairment in primary care. Int J Geriatr Psychiatry 2006; 21:349-55.
15. U.S. Preventive Services Task Force. Screening for dementia: recommendation and rationale. Ann Intern Med 2003; 138:925-6.
16. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56:1133-42.
17. American Medical Association. Practical guide for the primary care physician on the diagnosis, management and treatment of dementia. Chicago, IL: Program on Aging and Community Health, 2001.
18. Power C, Selnes OA, Grim JA, McArthur JC. HIV Dementia Scale: A rapid screening test. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8:273-8.
19. Berghuis JP, Uldall KK, Lalonde B. Validity of two scales in identifying HIV-associated dementia. J Acquir Immune Defic Syndr 1999; 21:134-40. (Pubitemid 29250077)
20. Bottiggi KA, Chang JJ, Schmitt FA, et al. The HIV Dementia Scale: Predictive power in mild dementia and HAART. J Neurol Sci 2007; 260:11-5. (Pubitemid 47212187)
21. Richardson MA, Morgan EE, Vielhauer MJ, Cuevas CA, Buondonno LM, Keane TM. Utility of the HIV dementia scale in assessing risk for significant HIV-related cognitive-motor deficits in a high-risk urban adult sample. AIDS Care 2005; 17:1013-21. (Pubitemid 41499314)
22. Smith CA, van Gorp WG, Ryan ER, Ferrando SJ, Rabkin J. Screening subtle HIV-related cognitive dysfunction: the clinical utility of the HIV dementia scale. J Acquir Immune Defic Syndr 2003; 33:116-8. (Pubitemid 36547251)
23. Morgan EE, Woods SP, Scott JC, et al. Predictive validity of demographically adjusted normative standards for the HIV Dementia Scale. J Clin Exp Neuropsychol 2008; 30:83-90.
24. Davis HF, Skolasky RL Jr, Selnes OA, Burgess DM, McArthur JC. Assessing HIV-associated dementia: Modified HIV dementia scale versus the Grooved Pegboard. AIDS Read 2002; 12:29-31, 38.
25. Waldrop-Valverde D, Nehra R, Sharma S, et al. Education effects on the international HIV dementia scale. J Neurovirol 2010; 16:264-7.
26. Rourke SB, Halman MH, Bassel C. Neurocognitive complaints in HIVinfection and their relationship to depressive symptoms and neuropsychological functioning. J Clin Exp Neuropsychol 1999; 21:737-56.
27. Woods SP, Moore DJ, Weber E, Grant I. Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev 2009; 19:152-68.
28. Cysique LA, Murray JM, Dunbar M, Jeyakumar V, Brew BJ. A screening algorithm for HIV-associated neurocognitive disorders. HIV Med 2010; 11:642-9.
29. Gonzalez R, Heaton RK, Moore DJ, et al. Computerized reaction time battery versus a traditional neuropsychological battery: Detecting HIV-related impairments. J Int Neuropsychol Soc 2003; 9:64-71. (Pubitemid 36150139)
30. Worth JL, Savage CR, Baer L, Esty EK, Navia BA. Computer-based neuropsychological screening for AIDS dementia complex. AIDS 1993; 7:677-81. (Pubitemid 23204961)
31. Cysique LA, Maruff P, Darby D, Brew BJ. The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery. Arch Clin Neuropsychol 2006; 21:185-94. (Pubitemid 43117194)
32. Becker JT, Dew MA, Aizenstein HJ, Lopez OL, Morrow L, Saxton J. Concurrent validity of a computer-based cognitive screening tool for use in adults with HIV disease. AIDS Patient Care STDS 2011; 25:351-7.
33. Carey CL, Woods SP, Rippeth JD, et al. Initial validation of a screening battery for the detection of HIV-associated cognitive impairment. Clin Neuropsychol 2004; 18:234-48. (Pubitemid 39180728)
34. Valcour VG, Shiramizu BT, Sithinamsuwan P, et al. HIV DNA and cognition in a Thai longitudinal HAART initiation cohort: The SEARCH 001 Cohort Study. Neurology 2009; 72:992-8.
35. Ellis RJ, Evans SR, Clifford DB, et al. Clinical validation of the NeuroScreen. J Neurovirol 2005; 11:503-11. (Pubitemid 43123769)
36. Ganasen KA, Fincham D, Smit J, Seedat S, Stein D. Utility of the HIV Dementia Scale (HDS) in identifying HIV dementia in a South African sample. J Neurol Sci 2008; 269:62-4.
37. Skinner S, Adewale AJ, DeBlock L, Gill MJ, Power C. Neurocognitive screening tools in HIV/AIDS: Comparative performance among patients exposed to antiretroviral therapy. HIV Med 2009; 10:246-52.
38. Milne A. Dementia screening and early diagnosis: The case for and against. Health Risk Soc 2010; 12:65-76.
39. Marra CM, Zhao Y, Clifford DB, et al. AIDS Clinical Trials Group 7736 Study Team. Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS 2009; 23:1359-66.
40. Overton E, Ances B, Grubb J, et al. Novel screening tools for HIVassociated neurocognitive disorders. Paper presented at: 18th Conference on Retroviruses and Opportunistic Infections; 27 February-8 March 2011; Boston, MA. Paper 401.
41. Koski L, Brouillette MJ, Lalonde R, et al. Computerized testing augments pencil-and-paper tasks in measuring HIV-associated mild cognitive impairment. HIV Med 2011; 12:472-80.